FindTrial
Sign In

Total testosterone level in women undergoing ovarian stimulation and its impact on Assisted Reproductive Technique cycles

Serum total testosterone level in women undergoing ovarian stimulation and its impact on Assisted Reproductive Technique cycles - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059971
Enrollment
103
Registered
2023-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Controlled Ovarian stimulation cycles with antagonist protocol Normal ovarian reserve

Exclusion criteria

Exclusion criteria: Patients with earlier poor ovarian response Poor ovarian reserve patient- Antral Follicle Count <5, Anti Mullerian hormone <1.2 ng/ml

Design outcomes

Primary

MeasureTime frame
evaluating testosterone levels in womenTimepoint: evaluating testosterone levels in women- Baseline—

Secondary

MeasureTime frame
impact of testosterone levels on oocyte & embryo qualityTimepoint: impact of testosterone levels on oocyte & embryo quality on the day of oocyte pickup & 3 days after that—

Countries

India

Contacts

Public ContactDr. Ayushi Agarwal

Kasturba Medical College, Manipal

anjali.suneel@manipal.edu9455273959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026